UnitedHealth Group Inc. (NYSE:UNH) issued its quarterly earnings data on Tuesday. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the prior year, the business posted $1.77 EPS.
Shares of UnitedHealth Group (NYSE:UNH) opened at 134.13 on Tuesday. The stock’s 50 day moving average is $136.95 and its 200 day moving average is $136.65. The stock has a market cap of $127.74 billion, a price-to-earnings ratio of 20.99 and a beta of 0.57. UnitedHealth Group has a 52-week low of $107.51 and a 52-week high of $144.48.
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is presently 39.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.65% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of UnitedHealth Group by 0.8% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 219,225 shares of the healthcare conglomerate’s stock valued at $30,955,000 after buying an additional 1,681 shares during the last quarter. Bellwether Investment Group LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at $220,000. M Holdings Securities Inc. raised its position in shares of UnitedHealth Group by 48.6% in the second quarter. M Holdings Securities Inc. now owns 4,368 shares of the healthcare conglomerate’s stock valued at $617,000 after buying an additional 1,428 shares during the last quarter. Wedge Capital Management L L P NC raised its position in shares of UnitedHealth Group by 4.0% in the second quarter. Wedge Capital Management L L P NC now owns 439,614 shares of the healthcare conglomerate’s stock valued at $62,073,000 after buying an additional 16,765 shares during the last quarter. Finally, Cypress Capital Group raised its position in shares of UnitedHealth Group by 6.1% in the second quarter. Cypress Capital Group now owns 4,493 shares of the healthcare conglomerate’s stock valued at $634,000 after buying an additional 260 shares during the last quarter. Institutional investors own 85.80% of the company’s stock.
UNH has been the subject of a number of research analyst reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, June 27th. Wolfe Research initiated coverage on UnitedHealth Group in a research note on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 target price for the company. Credit Suisse Group AG restated a “buy” rating and issued a $148.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Sanford C. Bernstein initiated coverage on UnitedHealth Group in a research note on Friday, July 15th. They issued an “outperform” rating for the company. One research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $155.35.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.